摘要:
A method in a controller for a first cell in a mobile cellular network for making a decision to handover a user equipment to a second cell of the mobile cellular network is described. The method may include obtaining a first measurement of an uplink signal from a user equipment at the first cell, obtaining a second measurement of an uplink signal from the user equipment at the second cell, and making a decision to handover the user equipment from the first cell to the second cell using the obtained first and second measurements.
摘要:
Embodiments herein relate to a method in a radio base station (12) for scheduling a radio resource to a first user equipment (10). The radio base station (12) is comprised in a radio communications network and controls a number of radio resources to be scheduled for communication to a number of user equipments (10,11). The number of user equipments comprises the first user equipment (10) and being served by the radio base station (12). The scheduling is based on channel quality of channels used by the respective user equipments. The radio base station (12) estimates a first channel quality of a channel used by the first user equipment (10). The radio base station determines a pathloss between the first user equipment (10) and the radio base station (12), and computes a second channel quality of the channel based on the estimated first channel quality and the determined pathloss. The radio base station (12) then schedules a radio resource out of the number of radio resources to the first user equipment (10) based on the second channel quality.
摘要:
The present invention relates to compounds, including compounds of Formula I, or a pharmaceutically acceptable salt, ester, or prodrug, thereof: which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
摘要:
The present invention is directed to a hemostatic material comprising a scaffold and a galvanic particulate. The galvanic particulate comprises particles made of at least two dissimilar metals. The scaffold is preferably a biocompatible polysaccharide-based hemostatic, such as a chitosan or cellulosic based hemostatic like ORC.
摘要:
A chain-type magazine includes a box, a chain-type conveyor and a spinning unit. The box includes a port defined therein. The chain-type conveyor includes links connected to one another so that each of the links can be pivoted relative to the other links about two axes in parallel to each other. A tool can be inserted in a holder inserted in each of the links. The spinning unit includes a mounting assembly, an elevating assembly, a rotary claw assembly and a connecting rod. The mounting assembly is connected to the box. The elevating assembly is movably connected to the mounting assembly. The rotary claw assembly is rotationally connected to the mounting assembly for catching a selected one of the links. The connecting rod connects the elevating assembly to the rotary claw assembly. The driving element drives the elevating assembly to spin the rotary claw assembly.
摘要:
An administrator of an enterprise storage set may be tasked with storing a large number and variety of data sets on a large number and variety of storage components. However, the manual selection of a physical schema by an administrator may be time-consuming, may generate inefficient physical schemata, and may not be easily reevaluated as the data sets and storage set change. Presented herein are techniques for automatically determining a physical schema by comparing the storage factors of each data set (e.g., data size, relationships with other data sets, and usages of the data set by users) with the storage capabilities of the storage components, selecting a suitable storage component, and implementing the storage of the data set on the storage component. An embodiment of these techniques may thereby achieve an automated identification of a physical schema with improved efficiency and flexibility of the physical schema while conserving administrative resources.
摘要:
A method for detection of the position and orientation of the tip of a needle-like medical device inserted into a tissue of a patient using scanning apparatus. The method obtains a first scan of the tissue correlating the needle-like medical device with a plurality of needle-like templates, each one having a different angular orientation to obtain an feature image of the device; obtains eigenvalues and an eigenvector of image to obtain the angular orientation of an image plane for a subsequent scan; transforms the orientation of the device in the determined image plane into scanning system reference coordinates with the longitudinal axis of the needle like device having a predetermined orientations with respect to the reference coordinate system; and makes observations along each of a sequence of lines transverse to the longitudinal axis of the image of the device in the determined plane to detect the tip of the device.
摘要:
Implantable medical devices having galvanic particulates are disclosed. The particulates may be coated onto at least part of a surface of the medical device. In addition, the galvanic particulates may be contained in the material used to manufacture the antimicrobial medical devices, or may be embedded into the surface of the medical devices. The present invention also provides novel coating methods and processing methods. The present invention further provides a combination of galvanic particulates with an aqueous gel, a method of making this combination, and a method of treatment using this combination. The devices and compositions may have advantageous characteristics and effects including anti-microbial, anti-inflammatory, tissue regeneration promoting, and pain reduction or elimination.
摘要:
Various schedulers are disclosed for use within a network node of a radio access network. A scheduler can be configured to divide a defined frequency bandwidth into a plurality of bandwidth pipes. The scheduler then develops sets of nodes that are candidates for using corresponding ones of the bandwidth pipes to communicate with the network node during a communication time interval. At least one of the sets contains a plurality of candidate nodes. The scheduler operates separate parallel processes that are arranged for computing metrics for the sets of nodes. The scheduler assigns one of the nodes in each set of nodes to the corresponding bandwidth pipe in response to the computed metrics. The scheduler may divide the defined frequency bandwidth into a plurality of non-overlapping bandwidth pipes so that metrics for candidate nodes in one of the sets can be computed independently from candidate nodes in another one of the sets.
摘要:
The present invention relates to compounds of Formula I, II or III, or a pharmaceutically acceptable salt, ester, or prodrug, thereof: wherein W is a substituted or unsubstituted heterocyclic ring system. The compounds inhibit serine protease activity, particularly the activity of hepatitis c virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis c virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.